Vincenzo Caiaffa
Research Subjects
Research Interests
Vincenzo Caiaffa has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Antonella Abate
Di Venere Hospital Bari
1 shared publicationDomenico Visceglie
Di Venere Hospital Bari
1 shared publicationFrancesco Ippolito
Di Venere Hospital Bari
1 shared publicationMichele Santodirocco
Apulia Cord Blood Bank Casa Sollievo della Sofferenza
1 shared publicationVittorio Nappi
Di Venere Hospital Bari
1 shared publication
Latest Publications
- 9 October 2020
- Published by Medical Association of Zenica-Doboj in Medicinski Glasnik
- Vol. 18 (1) , 260-266
Allogenic platelet concentrates from umbilical cord blood for knee osteoarthritis: preliminary results
Aim To investigate the role of cordonal blood platelet-rich plasma (PRP) intra-articular injections for treating the patients with kneeosteoarthritis in terms of procedure safety and clinical outcomes.Methods Twenty-five patients affected by knee osteoarthritis were enrolled and received one single intra-articular knee injection ofumbilical cord PRP in a volume of 10 mL. A follow-up was investigated at time 0, 4, 8, 12 weeks and 6 months, evaluating clinical parameters and functional performances.Results No serious adverse events were identified. The paired ttest analysis showed a significant difference between baseline andeach follow-up times for all clinical scales (p<0.05), with a significant improvement of clinical outcomes.Conclusion Allogeneic PRP can generate reliable therapeutic effect. The high content of tissue regenerative factors in cord blood platelets makes cordonal blood one of the ideal sources of PRP.
- 9 October 2020
- Published by Medical Association of Zenica-Doboj in Medicinski Glasnik
- Vol. 18 (1) , 260-266
Allogenic platelet concentrates from umbilical cord blood for knee osteoarthritis: preliminary results
Aim To investigate the role of cordonal blood platelet-rich plasma (PRP) intra-articular injections for treating the patients with kneeosteoarthritis in terms of procedure safety and clinical outcomes.Methods Twenty-five patients affected by knee osteoarthritis were enrolled and received one single intra-articular knee injection ofumbilical cord PRP in a volume of 10 mL. A follow-up was investigated at time 0, 4, 8, 12 weeks and 6 months, evaluating clinical parameters and functional performances.Results No serious adverse events were identified. The paired ttest analysis showed a significant difference between baseline andeach follow-up times for all clinical scales (p<0.05), with a significant improvement of clinical outcomes.Conclusion Allogeneic PRP can generate reliable therapeutic effect. The high content of tissue regenerative factors in cord blood platelets makes cordonal blood one of the ideal sources of PRP.